Alessandra Oliva, L Liguori, S Covino, F Petrucci, F Cogliati-Dezza, A Curtolo, G Savelloni, M Comi, F Sacco, G Ceccarelli, A Viscido, F Alessandri, G Raponi, F Pugliese, C M Mastroianni, M Venditti
BACKGROUND: We assessed the clinical effectiveness of cefiderocol (CFDC) in comparison with colistin (COL) for the treatment of carbapenem-resistant Acinetobacter baumannii (CRAB) bloodstream infections (BSI). MATERIALS/METHODS: Retrospective cohort study including adults with CRAB-BSI. Outcomes were mortality, clinical cure and adverse events during therapy. The average treatment effect of CFDC compared to COL was weighted with the inverse-probability treatment weight (IPTW)...
April 18, 2024: European Journal of Clinical Microbiology & Infectious Diseases